GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com
Patient Information Leaflet last updated on the eMC: 20/10/2008
PIL Augmentin 375mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 20/10/2008 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 24/01/2005 and displayed until 20/10/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 30/07/2004 and displayed until 24/01/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 14/05/2003 and displayed until 30/07/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 10/05/2002 and displayed until 14/05/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 20/09/2000 and displayed until 10/05/2002
Reasons for adding or updating:
  • No reasons supplied
Updated on 10/08/2000 and displayed until 20/09/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   co-amoxiclav


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk